Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome

Detalhes bibliográficos
Autor(a) principal: Teixeira Filho, Fabio Lopes [UNIFESP]
Data de Publicação: 2002
Outros Autores: Baracat, Edmund Chada [UNIFESP], Lee, Taek Hoo, Suh, Chang Suk, Matsui, Motozumi, Chang, R. Jeffrey, Shimasaki, Shunichi, Erickson, Gregory F.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1210/jcem.87.3.8316
http://repositorio.unifesp.br/handle/11600/26762
Resumo: Polycystic ovary syndrome (PCOS) is a major cause of female infertility. Despite substantial effort, the etiology and pathogenesis of PCOS and polycystic ovaries (PCO) in women remain unknown. Recent studies in laboratory animals have documented a link between dysfunction of two oocyte growth factors, growth differentiation factor-9 (GDF-9) and bone morphogenetic factor-15 (BMP-15), and aberrant folliculogenesis. Because aberrant follicle development is a hallmark of PCOS, we wondered whether the expression patterns of these growth factors might be disrupted in PCOS and PCO oocytes. To address this issue, we compared the pattern and level of expression of GDF-9 and BMP-15 mRNA in ovaries from normal cycling (n = 12), PCOS (n = 5), and PCO (n = 7) patients. in situ hybridization studies showed that the expression of GDF-9 and BMP-15 is restricted to the oocytes in all ovaries examined. Interestingly, a decreased level of GDF-9 signal was observed in developing PCOS and PCO oocytes, compared with normal. This difference was evident throughout folliculogenesis, beginning at recruitment initiation and continuing through the small Graafian follicle stage. By contrast, there were no qualitative or quantitative changes in the expression of BMP-15 mRNA in PCOS oocytes during folliculogenesis. There were also no significant differences between normal and PCOS and PCOs in the levels of the mRNA encoding the housekeeping gene, cyclophilin. Together, these results indicate that the expression of GDF-9 mRNA is delayed and reduced in PCOS and PCO oocytes during their growth and differentiation phase. Because oocyte-derived GDF-9 is crucial for normal folliculogenesis and female fertility, we suggest that a dysregulation of oocyte GDF-9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women.
id UFSP_605d9fc5ed337ebb6e11acf09c029814
oai_identifier_str oai:repositorio.unifesp.br/:11600/26762
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndromePolycystic ovary syndrome (PCOS) is a major cause of female infertility. Despite substantial effort, the etiology and pathogenesis of PCOS and polycystic ovaries (PCO) in women remain unknown. Recent studies in laboratory animals have documented a link between dysfunction of two oocyte growth factors, growth differentiation factor-9 (GDF-9) and bone morphogenetic factor-15 (BMP-15), and aberrant folliculogenesis. Because aberrant follicle development is a hallmark of PCOS, we wondered whether the expression patterns of these growth factors might be disrupted in PCOS and PCO oocytes. To address this issue, we compared the pattern and level of expression of GDF-9 and BMP-15 mRNA in ovaries from normal cycling (n = 12), PCOS (n = 5), and PCO (n = 7) patients. in situ hybridization studies showed that the expression of GDF-9 and BMP-15 is restricted to the oocytes in all ovaries examined. Interestingly, a decreased level of GDF-9 signal was observed in developing PCOS and PCO oocytes, compared with normal. This difference was evident throughout folliculogenesis, beginning at recruitment initiation and continuing through the small Graafian follicle stage. By contrast, there were no qualitative or quantitative changes in the expression of BMP-15 mRNA in PCOS oocytes during folliculogenesis. There were also no significant differences between normal and PCOS and PCOs in the levels of the mRNA encoding the housekeeping gene, cyclophilin. Together, these results indicate that the expression of GDF-9 mRNA is delayed and reduced in PCOS and PCO oocytes during their growth and differentiation phase. Because oocyte-derived GDF-9 is crucial for normal folliculogenesis and female fertility, we suggest that a dysregulation of oocyte GDF-9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women.Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USAUniversidade Federal de São Paulo, BR-01311940 São Paulo, BrazilKyungpook Natl Univ, Taegu 700721, South KoreaSeoul Natl Univ, Coll Med, Seoul 110744, South KoreaUniversidade Federal de São Paulo, BR-01311940 São Paulo, BrazilWeb of ScienceEndocrine SocUniv Calif San DiegoUniversidade Federal de São Paulo (UNIFESP)Kyungpook Natl UnivSeoul Natl UnivTeixeira Filho, Fabio Lopes [UNIFESP]Baracat, Edmund Chada [UNIFESP]Lee, Taek HooSuh, Chang SukMatsui, MotozumiChang, R. JeffreyShimasaki, ShunichiErickson, Gregory F.2016-01-24T12:33:16Z2016-01-24T12:33:16Z2002-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1337-1344http://dx.doi.org/10.1210/jcem.87.3.8316Journal of Clinical Endocrinology & Metabolism. Chevy Chase: Endocrine Soc, v. 87, n. 3, p. 1337-1344, 2002.10.1210/jcem.87.3.83160021-972Xhttp://repositorio.unifesp.br/handle/11600/26762WOS:000174620600060engJournal of Clinical Endocrinology & Metabolisminfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T10:33:16Zoai:repositorio.unifesp.br/:11600/26762Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T10:33:16Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
title Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
spellingShingle Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
Teixeira Filho, Fabio Lopes [UNIFESP]
title_short Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
title_full Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
title_fullStr Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
title_full_unstemmed Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
title_sort Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
author Teixeira Filho, Fabio Lopes [UNIFESP]
author_facet Teixeira Filho, Fabio Lopes [UNIFESP]
Baracat, Edmund Chada [UNIFESP]
Lee, Taek Hoo
Suh, Chang Suk
Matsui, Motozumi
Chang, R. Jeffrey
Shimasaki, Shunichi
Erickson, Gregory F.
author_role author
author2 Baracat, Edmund Chada [UNIFESP]
Lee, Taek Hoo
Suh, Chang Suk
Matsui, Motozumi
Chang, R. Jeffrey
Shimasaki, Shunichi
Erickson, Gregory F.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Univ Calif San Diego
Universidade Federal de São Paulo (UNIFESP)
Kyungpook Natl Univ
Seoul Natl Univ
dc.contributor.author.fl_str_mv Teixeira Filho, Fabio Lopes [UNIFESP]
Baracat, Edmund Chada [UNIFESP]
Lee, Taek Hoo
Suh, Chang Suk
Matsui, Motozumi
Chang, R. Jeffrey
Shimasaki, Shunichi
Erickson, Gregory F.
description Polycystic ovary syndrome (PCOS) is a major cause of female infertility. Despite substantial effort, the etiology and pathogenesis of PCOS and polycystic ovaries (PCO) in women remain unknown. Recent studies in laboratory animals have documented a link between dysfunction of two oocyte growth factors, growth differentiation factor-9 (GDF-9) and bone morphogenetic factor-15 (BMP-15), and aberrant folliculogenesis. Because aberrant follicle development is a hallmark of PCOS, we wondered whether the expression patterns of these growth factors might be disrupted in PCOS and PCO oocytes. To address this issue, we compared the pattern and level of expression of GDF-9 and BMP-15 mRNA in ovaries from normal cycling (n = 12), PCOS (n = 5), and PCO (n = 7) patients. in situ hybridization studies showed that the expression of GDF-9 and BMP-15 is restricted to the oocytes in all ovaries examined. Interestingly, a decreased level of GDF-9 signal was observed in developing PCOS and PCO oocytes, compared with normal. This difference was evident throughout folliculogenesis, beginning at recruitment initiation and continuing through the small Graafian follicle stage. By contrast, there were no qualitative or quantitative changes in the expression of BMP-15 mRNA in PCOS oocytes during folliculogenesis. There were also no significant differences between normal and PCOS and PCOs in the levels of the mRNA encoding the housekeeping gene, cyclophilin. Together, these results indicate that the expression of GDF-9 mRNA is delayed and reduced in PCOS and PCO oocytes during their growth and differentiation phase. Because oocyte-derived GDF-9 is crucial for normal folliculogenesis and female fertility, we suggest that a dysregulation of oocyte GDF-9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women.
publishDate 2002
dc.date.none.fl_str_mv 2002-03-01
2016-01-24T12:33:16Z
2016-01-24T12:33:16Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1210/jcem.87.3.8316
Journal of Clinical Endocrinology & Metabolism. Chevy Chase: Endocrine Soc, v. 87, n. 3, p. 1337-1344, 2002.
10.1210/jcem.87.3.8316
0021-972X
http://repositorio.unifesp.br/handle/11600/26762
WOS:000174620600060
url http://dx.doi.org/10.1210/jcem.87.3.8316
http://repositorio.unifesp.br/handle/11600/26762
identifier_str_mv Journal of Clinical Endocrinology & Metabolism. Chevy Chase: Endocrine Soc, v. 87, n. 3, p. 1337-1344, 2002.
10.1210/jcem.87.3.8316
0021-972X
WOS:000174620600060
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Journal of Clinical Endocrinology & Metabolism
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1337-1344
dc.publisher.none.fl_str_mv Endocrine Soc
publisher.none.fl_str_mv Endocrine Soc
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268424228962304